Financhill
Back

LifeMD Quote, Financials, Valuation and Earnings

LifeMD Price Quote

$5.04

LifeMD Key Stats

Sell
21
LifeMD (LFMD) is a Sell

Day range:
$4.76 - $5.17
52-week range:
$3.99 - $12.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.04
P/B ratio:
0%

Volume:
1.3M
Avg. volume:
825.5K
1-year change:
-37%
Market cap:
$218.3M
Revenue:
$152.5M
EPS:
$-0.64

How Much Does LifeMD Make?

Data Unavailable

Is LifeMD Growing As A Company?

Data Unavailable

LifeMD Stock Price Performance

  • Did LifeMD Stock Go Up Last Month?
    LifeMD share price went down by -7.01% last month
  • Did LFMD's Share Price Rise Over The Last Year?
    LFMD share price fell by -37% over the past 1 year

What Is LifeMD 52-Week High & Low?

  • What Is LifeMD’s 52-Week High Share Price?
    LifeMD has traded as high as $12.88 over the past 52 weeks
  • What Is LifeMD’s 52-Week Low Share Price?
    LifeMD has traded as low as $3.99 over the past 52 weeks

LifeMD Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy LifeMD?

Data Unavailable

Is LifeMD Cash Flow Positive?

Data Unavailable

LifeMD Return On Invested Capital

Data Unavailable

LifeMD Earnings Date & Stock Price

  • What Is LifeMD's Stock Price Today?
    A single share of LFMD can be purchased today for 5.04
  • What Is LifeMD’s Stock Symbol?
    LifeMD trades on the nasdaq under the ticker symbol: LFMD
  • When Is LifeMD’s Next Earnings Date?
    The next quarterly earnings date for LifeMD is scheduled on March 11, 2025
  • When Is LFMD's next ex-dividend date?
    LifeMD's next ex-dividend date is December 22, 2024
  • How To Buy LifeMD Stock?
    You can buy LifeMD shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

LifeMD Competitors

  • Who Are LifeMD's Competitors?
    Below is a list of companies who compete with LifeMD or are related in some way:
    • LENZ Therapeutics Inc (LENZ)
    • Veradigm Inc (MDRX)
    • Oruka Therapeutics Inc (ORKA)
    • Streamline Health Solutions Inc (STRM)
    • TruBridge Inc (TBRG)

LifeMD Dividend Yield

Data Unavailable

LifeMD Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 28.57%
Revenue: 38.27% -0.75%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 12.00
Upside from Last Price: 138.1%

Major Shareholders

Data Unavailable